The P Value Line Dance: When Does the Music Stop?

Area of Science:

• Clinical trial methodology
• Statistical inference
• Evidence-based medicine

Background:

• Traditional frequentist approaches to clinical trials often dichotomize results into significant or nonsignificant.
• This dichotomization can obscure the inherent uncertainty in scientific evidence and hinder adaptive decision-making.
• Concerns about type I and II errors and P value manipulation can complicate trial conduct.

Purpose of the Study:

• To critically evaluate the limitations of traditional hypothesis testing in clinical trials.
• To advocate for a shift in scientific focus from null hypothesis rejection to quantifying treatment effect uncertainty.
• To introduce Bayesian methods as a superior framework for adaptive trial decision-making.

Main Methods:

• Conceptual analysis of statistical inference in clinical trials.
• Discussion of the fickleness and limitations of P values over time.
• Introduction of Bayesian statistical principles for continuous evidence assessment.

Main Results:

• P values can fluctuate, leading to misleading conclusions about statistical significance as more data accrues.
• The focus on rejecting the null hypothesis can overshadow the primary scientific goal of understanding treatment effect uncertainty.
• Bayesian methods provide a framework for continuous evaluation of evidence.

Conclusions:

• Clinical trial design should prioritize unearthing treatment effect uncertainties rather than solely testing against the null hypothesis.
• Bayesian approaches facilitate continuous decision-making regarding trial continuation or cessation.
• Embracing uncertainty through Bayesian methods enhances the adaptive nature of scientific inquiry.